Wave Life Sciences Ltd. has appointed Dr. Christopher Wright as its new Chief Medical Officer. Dr. Wright will oversee global development, including medical, clinical, and regulatory functions, to advance the company's RNA medicines pipeline. He brings extensive experience in both rare and common diseases and has previously worked as a practicing neurologist and an Associate Professor of Neurology at Harvard Medical School.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.